[go: up one dir, main page]

MX2012001790A - Anticuerpos monoclonales para proteina pbp2-a y secuencias homologas para el tratamiento de infecciones e inmunodiagnostico en bacterias del filum firmicutes. - Google Patents

Anticuerpos monoclonales para proteina pbp2-a y secuencias homologas para el tratamiento de infecciones e inmunodiagnostico en bacterias del filum firmicutes.

Info

Publication number
MX2012001790A
MX2012001790A MX2012001790A MX2012001790A MX2012001790A MX 2012001790 A MX2012001790 A MX 2012001790A MX 2012001790 A MX2012001790 A MX 2012001790A MX 2012001790 A MX2012001790 A MX 2012001790A MX 2012001790 A MX2012001790 A MX 2012001790A
Authority
MX
Mexico
Prior art keywords
pbp2
protein
monoclonal antibodies
bacteria
immunodiagnostics
Prior art date
Application number
MX2012001790A
Other languages
English (en)
Inventor
Jose Procopio Moreno Senna
Joao Luiz Sampaio Queiroz
Nadia Maria Batoreau
Maria De Gloria Martins Teixeira
Original Assignee
Fundacao Oswaldo Cruz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacao Oswaldo Cruz filed Critical Fundacao Oswaldo Cruz
Priority claimed from PCT/BR2010/000263 external-priority patent/WO2011017791A1/pt
Publication of MX2012001790A publication Critical patent/MX2012001790A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565Complementarity determining region [CDR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención se refiere a anticuerpos monoclonales capaces de reconocer y unirse a la proteína PBP2a y otras proteínas presentando secuencias homólogas a PBP2a, incluyendo los patógenos Staphylococcus aureus resistentes a la meticilina - MRSA, Staphylococcus coagulasa-negativa, Staphylococcus sciuri, Enterococcus spp., y cualquier otra bacteria que posea PBP2a o secuencias homólogas a esta proteína; la invención todavía se refiere a la utilización de anticuerpos monoclonales capaces de reconocer y unirse a la proteína PBP2a y otras proteínas presentando secuencias homólogas a PBP2a en un inmunodiagnosis complementario para la detección de resistencia a beta-lactamas.
MX2012001790A 2009-08-10 2010-08-10 Anticuerpos monoclonales para proteina pbp2-a y secuencias homologas para el tratamiento de infecciones e inmunodiagnostico en bacterias del filum firmicutes. MX2012001790A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0976200 2009-08-10
PCT/BR2010/000263 WO2011017791A1 (pt) 2009-08-10 2010-08-10 Anticorpos monoclonais para a proteína pbp2-a e sequências homólogas para o tratamento de infeçcões e imunodiagnóstico em bactérias do filo firmicutes

Publications (1)

Publication Number Publication Date
MX2012001790A true MX2012001790A (es) 2012-04-30

Family

ID=46208248

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012001790A MX2012001790A (es) 2009-08-10 2010-08-10 Anticuerpos monoclonales para proteina pbp2-a y secuencias homologas para el tratamiento de infecciones e inmunodiagnostico en bacterias del filum firmicutes.

Country Status (4)

Country Link
US (1) US8940304B2 (es)
EP (1) EP2476702B1 (es)
ES (1) ES2773920T3 (es)
MX (1) MX2012001790A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014063703A1 (en) * 2012-10-22 2014-05-01 Statens Serum Institut Monoclonal antibodies
EP2889311B1 (en) 2013-12-30 2018-03-21 Albert-Ludwigs-Universität Freiburg Opsonic and protective monoclonal antibodies against gram-positive pathogens
EP3763737A1 (en) * 2019-07-12 2021-01-13 Eberhard Karls Universität Tübingen Binding compounds of penicillin binding protein 2 a

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8621910D0 (en) * 1986-09-11 1986-10-15 Technology Licence Co Ltd Monoclonal antibodies
EP1173485A1 (en) * 1999-05-03 2002-01-23 Medarex, Inc. Human antibodies to staphylococcus aureus
AU2006208226A1 (en) * 2005-01-24 2006-08-03 Amgen Inc. Humanized anti-amyloid antibody
FI118305B (fi) * 2006-03-24 2007-09-28 Metso Paper Inc Menetelmä ja sovitelma päällystemäärän hallitsemiseksi kuiturainan päällystyksessä

Also Published As

Publication number Publication date
US20120195907A1 (en) 2012-08-02
US8940304B2 (en) 2015-01-27
ES2773920T3 (es) 2020-07-15
EP2476702B1 (en) 2019-12-25
EP2476702A1 (en) 2012-07-18
EP2476702A4 (en) 2013-05-01

Similar Documents

Publication Publication Date Title
WO2009085221A3 (en) Detection of methicillin-resistant staphylococcus aureus
WO2013109302A3 (en) Chromatography matrices including novel staphylococcus aureus protein a based ligands
WO2013025834A3 (en) Compositions and methods related to antibodies to staphylococcal protein a
EA200901617A1 (ru) Борсодержащие молекулы небольшого размера
EA201491646A1 (ru) Аналоги антибиотика ариломицина широкого действия
BRPI0922220B8 (pt) uso de compostos antibacterianos, composição farmacêutica e combinação compreendendo os mesmos
EA201691766A1 (ru) Органические соединения, являющиеся монобактамами, для лечения бактериальных инфекций
HK1199792A1 (en) Antibacterial compounds and methods for use
EP2791362A4 (en) PROTEINS WITH MRSA PBP2A AND FRAGMENTS THEREOF, NUCLEIC ACIDS FOR CODING THEREOF AND PREPARATIONS AND THEIR USE FOR THE PREVENTION AND TREATMENT OF MRSA INFECTIONS
WO2011008092A4 (en) Gram-positive bacteria specific binding compounds
EA201190095A1 (ru) Производные актагардина
EA201590871A1 (ru) Макроциклические антибиотики широкого спектра действия
WO2009137677A3 (en) Reagents, methods, and systems for detecting methicillin-resistant staphylococcus
EP4477272A3 (en) Polymyxin derivatives as antimicrobial compounds
BR112017011478A2 (pt) composto de conjugado anticorpo-antibiótico, conjugado anticorpo-antibiótico, composição farmacêutica, métodos de tratamento de uma infecção bacteriana e para exterminar staph aureus, processo para a preparação do composto, kit e intermediário antibiótico-ligante
EA201390639A1 (ru) Производные 2-пиперазин-1-ил-4н-1,3-бензотиазин-4-она и их применение для лечения инфекций у млекопитающих
WO2017218922A8 (en) Compositions and methods for the treatment of bacterial infections
FR2998580B1 (fr) Marqueurs moleculaires et methodes pour l'identification des genotypes de palmier dattier
CA2863661C (en) Diagnostic peptides for lyme disease
MX2012001790A (es) Anticuerpos monoclonales para proteina pbp2-a y secuencias homologas para el tratamiento de infecciones e inmunodiagnostico en bacterias del filum firmicutes.
WO2013041663A3 (de) Modifizierte apidaecinderivate als antibiotische peptide
AU2010282162A8 (en) Monoclonal antibodies against the PBP2-a protein and homologous sequences for the treatment of infections by and immunodiagnostics of bacteria of the firmicutes phylum
WO2012122533A3 (en) Compositions and methods related to antibodies to staphylococcal proteins isda or isdb
UA102325C2 (uk) Антибіотик, що містить міметичне антитіло, спосіб його приготування та застосування
WO2006098621A3 (en) Cross-beta structure on microbial organisms

Legal Events

Date Code Title Description
FG Grant or registration